1 o methicillin, cefotaxime, penicillin G, and nafcillin.

2                                              Nafcillin and cefazolin are considered first-line therap

3 ) days, respectively, for those treated with nafcillin and cefazolin.

4 ands, ethidium, rhodamine 6G, ciprofloxacin, nafcillin, and Phe-Arg-beta-naphthylamide.

5                                In 9 cases of nafcillin discontinuation, treatment was changed to cefa

6  exclusion of such compounds, exemplified by nafcillin, from cells of the wild-type S. typhimurium wa

7                         More patients in the nafcillin group developed rash (13.9% vs 4.2%; P = .002)

8              Subinhibitory concentrations of nafcillin induced and prolonged mRNA for Panton-Valentin

9 ort analysis of patients treated with either nafcillin or cefazolin for MSSA infection in the outpati

10 sixty-six and 119 patients were treated with nafcillin or cefazolin, respectively.

11 ompared definitive therapy with cefazolin vs nafcillin or oxacillin among patients with MSSA infectio

12 r odds of recurrent infections compared with nafcillin or oxacillin for MSSA infections complicated b

13 efazolin compared with patients who received nafcillin or oxacillin, after controlling for other fact

14 I, .66-.90) compared with patients receiving nafcillin or oxacillin, after controlling for other fact

15 antistaphylococcal penicillin (oxacillin and nafcillin) or first-generation cephalosporin (cefazolin)

16  received definitive therapy with cefazolin, nafcillin, or oxacillin.

17                   First-line MSSA therapies (nafcillin, oxacillin, cefazolin) are generally avoided i

18 tion of vancomycin and a beta-lactam (either nafcillin, oxacillin, or cefazolin) for staphylococcal b

19                  PBP4 had a low affinity for nafcillin, reacted with a monoclonal antibody raised aga

20 leted the prespecified treatment course with nafcillin than with cefazolin (PAD rate, 33.8% vs 6.7%;

21                                              Nafcillin treatment was associated with higher rates of

22              The hazard ratio for PAD in the nafcillin vs cefazolin groups was 2.81 (95% confidence i